1. Academic Validation
  2. Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes

Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes

  • Biochem J. 2003 Jul 1;373(Pt 1):133-43. doi: 10.1042/BJ20030013.
Flavia A O'Rourke 1 Janice M LaPlante Maurice B Feinstein
Affiliations

Affiliation

  • 1 Department of Pharmacology, University of Connecticut Health Center, Farmington CT 06030, USA. orourke@nso1.uchc.edu
Abstract

We recently discovered a novel gene on chromosome 19p13.1 and its product, an integral endoplasmic reticulum (ER) membrane protein, termed CHERP (calcium homoeostasis endoplasmic reticulum protein). A monoclonal antibody against its C-terminal domain inhibits Ins(1,4,5) P (3)-induced CA(2+) release from ER membrane vesicles of many cell types, and an antisense-mediated knockdown of CHERP in human erythroleukemia (HEL) cells greatly impaired CA(2+) mobilization by Thrombin. In the present paper, we explore further CHERP's function in Jurkat T-lymphocytes. Confocal laser immunofluorescence microscopy showed that CHERP was co-localized with the Ins(1,4,5) P (3) receptor throughout the cytoplasmic and perinuclear region, as previously found in HEL cells. Transfection of Jurkat cells with a lac I-regulated mammalian expression vector containing CHERP antisense cDNA caused a knockdown of CHERP and impaired the rise of cytoplasmic CA(2+) (measured by fura-2 acetoxymethyl ester fluorescence) caused by phytohaemagglutinin (PHA) and Thrombin. A 50% fall of CHERP decreased the PHA-induced rise of the cytoplasmic free CA(2+) concentration ([CA(2+)](i)), but CA(2+) influx was unaffected. Greater depletion of CHERP (>70%) did not affect the concentration of Ins(1,4,5) P (3) receptors, but diminished the rise of [CA(2+)](i) in response to PHA to </=30% of that in control cells, decreased CA(2+) influx and slowed the initial rate of [CA(2+)](i) rise caused by thapsigargin, an inhibitor of the sarcoplasmic/endoplasmic-reticulum CA(2+)-ATPase, suggesting there was also some deficit in ER CA(2+) stores. In CHERP-depleted cells the CA(2+)-dependent activation and translocation of the key transcription factor NFAT (nuclear factor of activated T-cells) from cytoplasm to nucleus was suppressed. Furthermore, cell proliferation was greatly slowed (as in HEL cells) along with a 60% decrease in cyclin D1, a key regulator of progression through the G(1) phase of the cell cycle. These findings provide further evidence that CHERP is an important component of the ER CA(2+)-mobilizing system in cells, and its loss impairs CA(2+)-dependent biochemical pathways and progression through the cell cycle.

Figures